Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sitagliptin.

Literature DB >> 17342863

Sitagliptin.

Daniel Drucker, Chris Easley, Peter Kirkpatrick.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2007 PMID： 17342863 DOI： 10.1038/nrd2245

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

Review 1. Natural products as inspiration for the development of asymmetric catalysis.

Authors: Justin T Mohr; Michael R Krout; Brian M Stoltz
Journal: Nature Date: 2008-09-18 Impact factor: 49.962

Review 2. The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors: Jonathan Z Long; Benjamin F Cravatt
Journal: Chem Rev Date: 2011-06-23 Impact factor: 60.622

3. Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland.

Authors: Antonis Voutetakis; Ana P Cotrim; Anne Rowzee; Changyu Zheng; Trushar Rathod; Tulin Yanik; Y Peng Loh; Bruce J Baum; Niamh X Cawley
Journal: Endocrinology Date: 2010-07-07 Impact factor: 4.736

4. Gliptins: a new class of oral antidiabetic agents.

Authors: K G Seshadri; M H B Kirubha
Journal: Indian J Pharm Sci Date: 2009-11 Impact factor: 0.975

Review 5. Regulation of glucose homeostasis by GLP-1.

Authors: Prashant Nadkarni; Oleg G Chepurny; George G Holz
Journal: Prog Mol Biol Transl Sci Date: 2014 Impact factor: 3.622

6. Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph⁺ chronic myeloid leukemia.

Authors: Michael Willmann; Irina Sadovnik; Gregor Eisenwort; Martin Entner; Tina Bernthaler; Gabriele Stefanzl; Emir Hadzijusufovic; Daniela Berger; Harald Herrmann; Gregor Hoermann; Peter Valent; Thomas Rülicke
Journal: Exp Hematol Date: 2017-10-12 Impact factor: 3.084

10. Effects of yam dioscorin interventions on improvements of the metabolic syndrome in high-fat diet-induced obese rats.

Authors: Shen-Liang Shih; Yin-Shiou Lin; Shyr-Yi Lin; Wen-Chi Hou
Journal: Bot Stud Date: 2015-02-25 Impact factor: 2.787

Sitagliptin.

Review 1. Natural products as inspiration for the development of asymmetric catalysis.

Review 2. The metabolic serine hydrolases and their functions in mammalian physiology and disease.

3. Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland.

4. Gliptins: a new class of oral antidiabetic agents.

Review 5. Regulation of glucose homeostasis by GLP-1.

6. Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph⁺ chronic myeloid leukemia.

7. Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.

Review 8. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.

9. Stimulating β-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor.

10. Effects of yam dioscorin interventions on improvements of the metabolic syndrome in high-fat diet-induced obese rats.

Sitagliptin.

Review 1. Natural products as inspiration for the development of asymmetric catalysis.

Review 2. The metabolic serine hydrolases and their functions in mammalian physiology and disease.

3. Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland.

4. Gliptins: a new class of oral antidiabetic agents.

Review 5. Regulation of glucose homeostasis by GLP-1.

6. Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia.

7. Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.

Review 8. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.

9. Stimulating β-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor.

10. Effects of yam dioscorin interventions on improvements of the metabolic syndrome in high-fat diet-induced obese rats.

6. Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph⁺ chronic myeloid leukemia.